Green Cross Holdings Corporation (005250.KS)
KRW 13550.0
(0.67%)
KRW 13550.0
(0.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -16.43 Billion KRW | -130.68% |
| 2022 | 71.15 Billion KRW | -61.08% |
| 2021 | 182.82 Billion KRW | 158.47% |
| 2020 | 70.73 Billion KRW | 132.83% |
| 2019 | 30.37 Billion KRW | -38.42% |
| 2018 | 49.33 Billion KRW | -55.94% |
| 2017 | 111.97 Billion KRW | 12.81% |
| 2016 | 99.25 Billion KRW | -7.76% |
| 2015 | 107.6 Billion KRW | -6.58% |
| 2014 | 115.19 Billion KRW | 21.38% |
| 2013 | 94.9 Billion KRW | 6.66% |
| 2012 | 88.97 Billion KRW | -10.84% |
| 2011 | 99.8 Billion KRW | -35.53% |
| 2010 | 154.79 Billion KRW | 17.72% |
| 2009 | 131.49 Billion KRW | 108.82% |
| 2008 | 62.96 Billion KRW | -9.36% |
| 2007 | 69.47 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 10.8 Billion KRW | 134.16% |
| 2024 Q1 | -31.09 Billion KRW | -36.67% |
| 2023 Q1 | -26.97 Billion KRW | -20.29% |
| 2023 Q3 | 20.74 Billion KRW | 187.59% |
| 2023 Q2 | 7.21 Billion KRW | 126.74% |
| 2023 Q4 | -22.75 Billion KRW | -209.7% |
| 2023 FY | -21.82 Billion KRW | -130.68% |
| 2022 Q2 | 9.88 Billion KRW | -79.89% |
| 2022 Q3 | 44.93 Billion KRW | 354.46% |
| 2022 Q4 | -22.42 Billion KRW | -149.9% |
| 2022 Q1 | 49.16 Billion KRW | 380.43% |
| 2022 FY | 71.15 Billion KRW | -61.08% |
| 2021 Q1 | 13.17 Billion KRW | 190.63% |
| 2021 Q4 | -17.53 Billion KRW | -122.85% |
| 2021 FY | 182.82 Billion KRW | 158.47% |
| 2021 Q3 | 76.72 Billion KRW | 453.0% |
| 2021 Q2 | 13.87 Billion KRW | 5.3% |
| 2020 Q2 | 10.52 Billion KRW | 86.59% |
| 2020 Q1 | 5.63 Billion KRW | 127.73% |
| 2020 Q3 | 51.74 Billion KRW | 391.81% |
| 2020 FY | 70.73 Billion KRW | 132.83% |
| 2020 Q4 | -14.53 Billion KRW | -128.1% |
| 2019 Q2 | 12.35 Billion KRW | 448.4% |
| 2019 Q4 | -20.33 Billion KRW | -156.31% |
| 2019 FY | 30.37 Billion KRW | -38.42% |
| 2019 Q3 | 36.11 Billion KRW | 192.38% |
| 2019 Q1 | 2.25 Billion KRW | 118.33% |
| 2018 Q2 | 15.89 Billion KRW | -8.13% |
| 2018 Q3 | 28.43 Billion KRW | 78.92% |
| 2018 FY | 49.33 Billion KRW | -55.94% |
| 2018 Q1 | 17.29 Billion KRW | 293.97% |
| 2018 Q4 | -12.29 Billion KRW | -143.23% |
| 2017 FY | 111.97 Billion KRW | 12.81% |
| 2017 Q4 | 4.39 Billion KRW | -90.72% |
| 2017 Q3 | 47.29 Billion KRW | 13.27% |
| 2017 Q2 | 41.75 Billion KRW | 125.4% |
| 2017 Q1 | 18.52 Billion KRW | -22.02% |
| 2016 Q1 | 13.54 Billion KRW | 199.21% |
| 2016 Q2 | 25.67 Billion KRW | 89.61% |
| 2016 Q3 | 36.28 Billion KRW | 41.32% |
| 2016 Q4 | 23.75 Billion KRW | -34.52% |
| 2016 FY | 99.25 Billion KRW | -7.76% |
| 2015 FY | 107.6 Billion KRW | -6.58% |
| 2015 Q4 | 4.52 Billion KRW | -91.4% |
| 2015 Q3 | 52.6 Billion KRW | 50.46% |
| 2015 Q2 | 34.96 Billion KRW | 125.23% |
| 2015 Q1 | 15.52 Billion KRW | 10.78% |
| 2014 FY | 115.19 Billion KRW | 21.38% |
| 2014 Q3 | 55.83 Billion KRW | 124.28% |
| 2014 Q2 | 24.89 Billion KRW | 21.76% |
| 2014 Q1 | 20.44 Billion KRW | 105.98% |
| 2014 Q4 | 14.01 Billion KRW | -74.91% |
| 2013 Q4 | 9.92 Billion KRW | -78.95% |
| 2013 FY | 94.9 Billion KRW | 6.66% |
| 2013 Q1 | 15.67 Billion KRW | 4118.13% |
| 2013 Q2 | 22.14 Billion KRW | 41.21% |
| 2013 Q3 | 47.15 Billion KRW | 112.98% |
| 2012 Q3 | 46.51 Billion KRW | 145.68% |
| 2012 Q2 | 18.93 Billion KRW | -18.23% |
| 2012 Q1 | 23.15 Billion KRW | 2934.76% |
| 2012 FY | 88.97 Billion KRW | -10.84% |
| 2012 Q4 | 371.7 Million KRW | -99.2% |
| 2011 Q1 | 35.03 Billion KRW | 0.0% |
| 2011 Q3 | 49.79 Billion KRW | 84.23% |
| 2011 Q4 | 762.96 Million KRW | -98.47% |
| 2011 Q2 | 27.02 Billion KRW | -22.85% |
| 2011 FY | 99.8 Billion KRW | -35.53% |
| 2010 Q2 | 18.98 Billion KRW | -50.72% |
| 2010 Q3 | 21.66 Billion KRW | 14.08% |
| 2010 FY | 154.79 Billion KRW | 17.72% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 38.53 Billion KRW | 0.0% |
| 2009 Q3 | 6.52 Billion KRW | -40.05% |
| 2009 Q2 | 10.88 Billion KRW | 273.93% |
| 2009 Q1 | 2.91 Billion KRW | 0.0% |
| 2009 FY | 131.49 Billion KRW | 108.82% |
| 2009 Q4 | - KRW | -100.0% |
| 2008 Q3 | 1.18 Billion KRW | -91.71% |
| 2008 Q2 | 14.25 Billion KRW | 752.24% |
| 2008 Q1 | 1.67 Billion KRW | 0.0% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | 62.96 Billion KRW | -9.36% |
| 2007 Q1 | 4.87 Billion KRW | 0.0% |
| 2007 FY | 69.47 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 10.1 Billion KRW | 107.36% |
| 2007 Q3 | 11.21 Billion KRW | 10.96% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| ORIENT BIO Inc. | 1.45 Billion KRW | 1231.457% |
| Green Cross Holdings Corporation | 34.43 Billion KRW | 147.734% |
| Pharmicell Co., Ltd. | 950.99 Million KRW | 1828.494% |
| Green Cross Corporation | 34.43 Billion KRW | 147.734% |
| GeneOne Life Science, Inc. | -48.36 Billion KRW | 66.015% |
| Celltrion, Inc. | 651.43 Billion KRW | 102.523% |
| Samsung Biologics Co.,Ltd. | 1155.98 Billion KRW | 101.422% |
| SK bioscience Co.,Ltd. | -4.73 Billion KRW | -247.452% |
| SK Biopharmaceuticals Co., Ltd. | -37.52 Billion KRW | 56.191% |
| Prestige BioPharma Limited | -62.78 Billion KRW | 73.818% |